Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 11 Dec 2025

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system

in Pharmacoepidemiology

Tao Huang
Po Zhang
Yan Zhou
Lei Wang
Qing Zhang
Mingxing Li
Junli Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1719881

1,371 views

Original Research

Published on 02 Dec 2025

Knowledge, attitudes, and practices of pharmacists toward over-the-counter medication use in Iraq: a nationwide cross-sectional study

in Pharmacoepidemiology

Mohamed AbdElrahman
Mohammed D. Al-Rekabi
Ghadah Ali Al-Oudah
Aysam M. Fayed
Hasanain Kamil Owadh

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1669176

1,039 views

Original Research

Published on 28 Nov 2025

Real-world pharmacovigilance insights into drug-induced risk of alopecia

in Pharmacoepidemiology

Huixiang Li
Haijian Wei
Qiaoqiao Shentu
Jianxin Cui
Jiaojiao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1703423

1,731 views

Original Research

Published on 27 Nov 2025

Disproportionality analysis of taste disorders using the FDA adverse event reporting system and Japanese adverse drug event report databases

in Pharmacoepidemiology

Yoji Kyotani
Kiichi Nakahira
Masanori Yoshizumi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1659746

1,429 views

Original Research

Published on 26 Nov 2025

Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases

in Pharmacoepidemiology

Jun-Wei Li
Xin-Dong Lei
Bing Dai

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1707885

1,558 views

Original Research

Published on 25 Nov 2025

Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030

in Pharmacoepidemiology

Wenshuo Jiang
Zhigang Zhao
Bin Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1669269

1,634 views

Original Research

Published on 24 Nov 2025

Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases

in Pharmacoepidemiology

Satoko Watanabe
Kyosuke Nagura
Naoto Okada
Taro Watanabe
Hidenori Sagara

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1700589

1,958 views

Original Research

Published on 21 Nov 2025

Comparative safety profile of levofloxacin versus moxifloxacin in first-line tuberculosis therapy: a pharmacovigilance study of the FAERS database

in Pharmacoepidemiology

Yanlang He
Lifen Liang
Sheng Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1713170

1,861 views

Original Research

Published on 19 Nov 2025

Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis

in Pharmacoepidemiology

Alberto Spadotto
Michele Fusaroli
Maria Carelli
Elena Nardi
Martina Amadori
Giulia Massaro
Veronica De Angelis
Milo Gatti
Valerio Ciubine
Emanuel Raschi

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1638923

1,466 views

Original Research

Published on 18 Nov 2025

Constructing an evaluation framework for primary pharmacovigilance systems in developing countries: a case study from China

in Pharmacoepidemiology

Shuang Lei
Shuzhi Lin
Xiaoying Zhu
Wei Liu
Qian Liu
Lin Yin
Bianling Feng

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1657574

1,001 views

Original Research

Published on 13 Nov 2025

Evaluation of standard use of intravenous infusion in 25 general hospitals in Shanxi province based on factor analysis and cluster analysis

in Pharmacoepidemiology

Lin Chen
Song Wang
Jinju Duan
Rong Yu
Ruigang Hou
Donghong Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1708461

960 views

Original Research

Published on 12 Nov 2025

Comparative safety analysis of Riluzole, Edaravone and Tofersen in ALS management: insights from FAERS database

in Pharmacoepidemiology

Shuang Guan
Sicun Wang
Yinli Shi
Yuanyuan Leng
Yu Ming
Zhiyong Hou
Yanan Yu
Zhong Wang
Jun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1687698

3,547 views

Original Research

Published on 11 Nov 2025

HPV vaccine-related thyroid adverse events: temporal patterns and reporting trends

in Pharmacoepidemiology

Liying Song
Jingkai Di
Jiaolin Fan
Rongrong Xi
Siyu Liang
Guosheng Duan
Yuanzheng Ding
Shuai Hao
Jing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1664697

3,875 views

Original Research

Published on 11 Nov 2025

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for etrasimod

in Pharmacoepidemiology

Yingxiu Wu
Wei Ke
Huibiao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1693090

2,476 views

Original Research

Published on 10 Nov 2025

The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database

in Pharmacoepidemiology

Zujun Wen
Xiang Liu
Yanbin Yi
Gengliang Lin
Peng Liu
Tingting Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1702875

1,912 views

Original Research

Published on 10 Nov 2025

The correlation between the use of ondansetron and mortality in sepsis associated encephalopathy patients: a retrospective ICU cohort study

in Pharmacoepidemiology

Shuo Yang
Yi-Qu Wei
Ya-Zhou Liu
Xiao-Lin Wang
Jin-Xia Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1712328

1,593 views

Original Research

Published on 10 Nov 2025

Disproportionality evaluation of adverse effects and suicide/self-injury risk factors associated with vortioxetine: a large-scale pharmacovigilance study

in Pharmacoepidemiology

Xiangyu Li
Fang Yang
Lingjing Yuan
Li Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1689634

1,620 views

Original Research

Published on 03 Nov 2025

Medical dispensation in La Rioja, Spain: epidemiology and its relationship with social determinants: a descriptive study

in Pharmacoepidemiology

Gonzalo Aparicio-Rodríguez
Raúl Juárez-Vela
Amaya Burgos-Esteban
Consuelo Sancho-Sánchez
José Ángel Santos-Sanchez
Noelia Navas-Echazarreta
Ana Cobos-Rincón
Antonio Cardoso-Muñoz
Regina Ruiz de Viñaspre-Hernández
Ignacio M. Larrayoz

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667148

1,615 views

Original Research

Published on 29 Oct 2025

Implementation of pharmacist recommendations following medication reviews in aged care

in Pharmacoepidemiology

Noah C. Ramsey
Gregory M. Peterson
Corinne Mirkazemi
Mohammed S. Salahudeen

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1690600

1,566 views

Original Research

Published on 23 Oct 2025

Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience

in Pharmacoepidemiology

Daniele Mengato
Laura Camuffo
Federica Todino
Luisella Cordiano
Domenica Condello
Catia Bucciol
Franca Benini
Francesco Paolo Russo
Alberto Cipriani
Stefano Sartori

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1706056

1,637 views

Original Research

Published on 21 Oct 2025

Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database

in Pharmacoepidemiology

Xiaozhi Li
Xiaofen Wen
Hongbo Fu
Xiaobing Hong
Danxia Lin
Xiaoyan Li
Zhikun Liang
Mengna Wang
Xihui Yu
Yanqiong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1700469

1,904 views

Original Research

Published on 20 Oct 2025

Real-world feasibility of co-administration of RSV, COVID-19, and influenza vaccines in older adults: a VAERS-based analysis

in Pharmacoepidemiology

Zhen Wei
Shilun Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1682119

3,008 views

Original Research

Published on 16 Oct 2025

Personalizing voriconazole dosing in Chinese hematological patients: CYP2C19 phenotype and albumin-bilirubin grade as key predictors of trough concentrations

in Pharmacoepidemiology

Lin Hu
Xi Tang
Yanfei Li
Juanjuan Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1667461

1,099 views

Original Research

Published on 16 Oct 2025

Prediction of long-term adherence to direct oral anti-coagulants in patients with atrial fibrillation using first-order Markov models

in Pharmacoepidemiology

Elias Edward Tannous
Shlomo Selitzky
Shlomo Vinker
Nicola Toukan
David Stepensky
Eyal Schwarzberg

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1673919

1,129 views

601 articles

articles

Disproportionality analysis of safety signals for milnacipran and levomilnacipran: a pharmacovigilance study using the FDA adverse event reporting system

Knowledge, attitudes, and practices of pharmacists toward over-the-counter medication use in Iraq: a nationwide cross-sectional study

Real-world pharmacovigilance insights into drug-induced risk of alopecia

Disproportionality analysis of taste disorders using the FDA adverse event reporting system and Japanese adverse drug event report databases

Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases

Trend analysis and future projections of global burden of opioid use disorder (OUD) from 1990 to 2030

Disproportionality analysis of biliary adverse events associated with fibrates using the JADER and FAERS databases

Comparative safety profile of levofloxacin versus moxifloxacin in first-line tuberculosis therapy: a pharmacovigilance study of the FAERS database

Ivabradine, atrial fibrillation and stroke: a combined meta-analysis and FAERS disproportionality analysis

Constructing an evaluation framework for primary pharmacovigilance systems in developing countries: a case study from China

Evaluation of standard use of intravenous infusion in 25 general hospitals in Shanxi province based on factor analysis and cluster analysis

Comparative safety analysis of Riluzole, Edaravone and Tofersen in ALS management: insights from FAERS database

HPV vaccine-related thyroid adverse events: temporal patterns and reporting trends

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for etrasimod

The real-world safety profile of ranolazine: pharmacovigilance analysis of the FAERS database

The correlation between the use of ondansetron and mortality in sepsis associated encephalopathy patients: a retrospective ICU cohort study

Disproportionality evaluation of adverse effects and suicide/self-injury risk factors associated with vortioxetine: a large-scale pharmacovigilance study

Medical dispensation in La Rioja, Spain: epidemiology and its relationship with social determinants: a descriptive study

Implementation of pharmacist recommendations following medication reviews in aged care

Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience

Drug-associated serotonin syndrome in elderly patients: a comprehensive disproportionality analysis based on the FAERS database

Real-world feasibility of co-administration of RSV, COVID-19, and influenza vaccines in older adults: a VAERS-based analysis

Personalizing voriconazole dosing in Chinese hematological patients: CYP2C19 phenotype and albumin-bilirubin grade as key predictors of trough concentrations

Prediction of long-term adherence to direct oral anti-coagulants in patients with atrial fibrillation using first-order Markov models